Hasan A, Visrodia K, Farrell JJ, Gonda TA. Overview and comparison of guidelines for management of pancreatic cystic neoplasms. World J Gastroenterol 2019; 25(31): 4405-4413 [PMID: 31496620 DOI: 10.3748/wjg.v25.i31.4405]
Corresponding Author of This Article
Tamas A Gonda, MD, Assistant Professor, Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, 161 Ft.Washington Ave, New York, NY 10032, United States. tg2214@cumc.columbia.edu
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Aug 21, 2019; 25(31): 4405-4413 Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4405
Overview and comparison of guidelines for management of pancreatic cystic neoplasms
Aws Hasan, Kavel Visrodia, James J Farrell, Tamas A Gonda
Aws Hasan, Kavel Visrodia, Tamas A Gonda, Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, NY 10032, United States
James J Farrell, Division of Digestive Diseases, Department of Medicine, Yale University, New Haven, CT 06520, United States
Author contributions: Gonda TA and Farrell JJ designed research; Hasan A and Visrodia K performed research; Hasan A, Visrodia K and Gonda TA wrote the paper. An author may list more than one contribution, and more than one author may have contributed to the same aspect.
Conflict-of-interest statement: The authors have declared no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Tamas A Gonda, MD, Assistant Professor, Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, 161 Ft.Washington Ave, New York, NY 10032, United States. tg2214@cumc.columbia.edu
Telephone: +1-212-3051909 Fax: +1-212-3051081
Received: April 19, 2019 Peer-review started: April 19, 2019 First decision: June 10, 2019 Revised: July 15, 2019 Accepted: July 19, 2019 Article in press: July 19, 2019 Published online: August 21, 2019 Processing time: 125 Days and 6.3 Hours
Abstract
Pancreatic cysts are identified at an increasing frequency. Although mucinous cystic neoplasms represent a pre-malignant condition, the majority of these lesions do not progress to cancer. Over the last 10 years several societies have established guidelines for the diagnosis, initial evaluation and surveillance of these lesions. Here we provide an overview of five commonly used guidelines: 2015 American Gastroenterological Association, 2017 International Association of Pancreatology, American College of Gastroenterology 2018, European Study Group and American College of Radiology. We describe the similarities and differences between the methods used to formulate these guidelines, the population they target and their approaches towards initial evaluation and surveillance of cystic lesions.
Core tip: There are multiple different guidelines with the aim of establishing set guidelines for surveillance of pancreatic cysts. Our review article summarizes four of the most commonly used guidelines for pancreatic cyst.
